Granules India Gets US FDA's Voluntary Action Indicated Classification for Bonthapally, India Unit

MT Newswires Live

10/29

Pharmaceutical manufacturing company Granules India (NSE:GRANULES, BOM:532482) received an establishment inspection report (EIR) with an inspection classification of voluntary action indicated (VAI) for its facility at Bonthapally in Hyderabad, India, according to a Wednesday filing to the Indian stock exchanges.

The company had received one observation from the US FDA after the inspection of its active pharmaceutical ingredients (API) facility conducted in June. The company had submitted its response within the stipulated time.

The facility manufactures Paracetamol API. It also has Metformin and Guaifenesin API manufacturing plants in the same facility.

The company's shares were up over 1% in recent trade.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2579240379"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2579240379\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2579240379?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-29 16:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579240379","market":"nz","top_or_hot":-1,"title":"Granules India Gets US FDA's Voluntary Action Indicated Classification for Bonthapally, India Unit","media":"MT Newswires Live","content":"<html><body><p> Pharmaceutical manufacturing company Granules India (NSE:GRANULES, BOM:532482) received an establishment inspection report (EIR) with an inspection classification of voluntary action indicated (VAI) for its facility at Bonthapally in Hyderabad, India, according to a Wednesday filing to the Indian stock exchanges.</p><p>The company had received one observation from the US FDA after the inspection of its active pharmaceutical ingredients (API) facility conducted in June. The company had submitted its response within the stipulated time.</p><p>The facility manufactures Paracetamol API. It also has Metformin and Guaifenesin API manufacturing plants in the same facility.</p><p>The company's shares were up over 1% in recent trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Granules India Gets US FDA's Voluntary Action Indicated Classification for Bonthapally, India Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGranules India Gets US FDA's Voluntary Action Indicated Classification for Bonthapally, India Unit\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-10-29 16:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Pharmaceutical manufacturing company Granules India (NSE:GRANULES, BOM:532482) received an establishment inspection report (EIR) with an inspection classification of voluntary action indicated (VAI) for its facility at Bonthapally in Hyderabad, India, according to a Wednesday filing to the Indian stock exchanges.</p><p>The company had received one observation from the US FDA after the inspection of its active pharmaceutical ingredients (API) facility conducted in June. The company had submitted its response within the stipulated time.</p><p>The facility manufactures Paracetamol API. It also has Metformin and Guaifenesin API manufacturing plants in the same facility.</p><p>The company's shares were up over 1% in recent trade.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4535","symbol_name":"淡馬錫持倉","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2579240379","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579240379","pubTimestamp":1761726140,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pharmaceutical manufacturing company Granules India  received an establishment inspection report  with an inspection classification of voluntary action indicated  for its facility at Bonthapally in Hyderabad, India, according to a Wednesday filing to the Indian stock exchanges.The company had received one observation from the US FDA after the inspection of its active pharmaceutical ingredients  facility conducted in June. The company had submitted its response within the stipulated time.The facility manufactures Paracetamol API. It also has Metformin and Guaifenesin API manufacturing plants in the same facility.The company's shares were up over 1% in recent trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4535":"淡马锡持仓","BK4503":"景林资产持仓","OTX.SI":"迈怡汇有限公司","BK6520":"工商业服务概念","API.AU":"Australian Pharma Industries","BK4023":"应用软件","BK4551":"寇图资本持仓","BK6100":"保健护理服务","API":"声网","BK7103":"保健护理产品经销商"},"translate_title":"印度颗粒获得美国FDA对印度Bonthapally工厂的自愿行动指示分类","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"API":1,"API.AU":1,"MNDmain":1.5,"OTX.SI":0.9},"content_text":"Pharmaceutical manufacturing company Granules India (NSE:GRANULES, BOM:532482) received an establishment inspection report (EIR) with an inspection classification of voluntary action indicated (VAI) for its facility at Bonthapally in Hyderabad, India, according to a Wednesday filing to the Indian stock exchanges.The company had received one observation from the US FDA after the inspection of its active pharmaceutical ingredients (API) facility conducted in June. The company had submitted its response within the stipulated time.The facility manufactures Paracetamol API. It also has Metformin and Guaifenesin API manufacturing plants in the same facility.The company's shares were up over 1% in recent trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}